Form 4: Abbott Laboratories Director Babineaux-Fontenot Reports Stock Award and Disposal

Director Claire Babineaux-Fontenot reports acquisition of restricted stock units and disposal of common shares of Abbott Laboratories.

Summary

• On April 25, 2025, Claire Babineaux-Fontenot, a director of Abbott Laboratories, reported a transaction involving the company's stock.
• She acquired 1,635 common shares through restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program.
• These restricted stock units will be paid in Abbott common shares on a one-to-one basis upon separation from service, death, or a change in control.
• She also disposed of 5,317 common shares.
• Following the reported transactions, Babineaux-Fontenot beneficially owns 5,317 common shares.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The restricted stock units will be paid out in Abbott common shares upon the director's separation from service, death, or a change in control, as defined in the Abbott Laboratories 2017 Incentive Stock Program.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common among publicly traded companies. It provides transparency into the trading activities of company directors and officers.

Stakeholder Impact

• Shareholders may be interested in the trading activity of company insiders as it can provide insights into management's perspective on the company's value.

Key Dates

Keywords

Abbott Laboratories, Director, Stock, Restricted Stock Units, Beneficial Ownership, Form 4, ABT, Insider Trading